Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies

Xin, Bernadette Jie Tune and Annatasha Stephen and Rhanye Mac Guad and Neeraj Kumar Fuloria and Vetriselvan Subramaniyan and Mahendran Sekar and Yuan, Seng Wu (2024) Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies. Progress In Drug Discovery & Biomedical Science. pp. 1-14. ISSN 2710-6039

	Text ABSTRACT.pdf Download (39kB)
	Text FULL TEXT.pdf Restricted to Registered users only Download (301kB) \| Request a copy

URL: https://journals.hh-publisher.com/index.php/pddbs/...

Abstract

Tuberculosis (TB) is an infection caused by the pathogen Mycobacterium tuberculosis. The disease causes around 2 million deaths worldwide, and incidences of drug resistance only makes increases the number. The most vulnerable victims of TB infections are children and human immunodeficiency virus (HIV) patients. TB and HIV co-infections can be deadly in AIDS sufferers, as the immune system is not able to combat TB infections, hence worsening the infection. Common drugs to treat TB are available in the market, first-line drugs such as isoniazid and rifamycin are broad-spectrum drugs. Second-line antibiotics such as fluoroquinolones are also available. In this review, the mechanisms of action of TB drugs are briefly discussed, as wells as the respective resistant mechanisms of M. tuberculosis against these drugs. An updated treatment regime for TB management using bedaquiline, pretomanid and linezolid was also discussed, which shows 90% therapeutic efficacy against highly drug-resistant tuberculosis cases. Furthermore, novel strategies such as nanoparticle-conjugated TB drugs can improve drug delivery, TB drug efficiency while reducing side effects. However, importance on patient compliance to the treatment regime is still the most crucial part of TB management, hence initiatives can be put to improve patient awareness and education.

Item Type:	Article
Keyword:	Tuberculosis, Mycobacterium tuberculosis, Drug resistance, Antibiotics
Subjects:	R Medicine > RC Internal medicine > RC31-1245 Internal medicine > RC306-320.5 Tuberculosis R Medicine > RM Therapeutics. Pharmacology > RM1-950 Therapeutics. Pharmacology > RM265-267 Antibiotic therapy. Antibiotics
Department:	FACULTY > Faculty of Medicine and Health Sciences
Depositing User:	SITI AZIZAH BINTI IDRIS -
Date Deposited:	12 Jun 2024 10:08
Last Modified:	12 Jun 2024 10:08
URI:	https://eprints.ums.edu.my/id/eprint/38830

Actions (login required)

View Item